...
首页> 外文期刊>Thoracic cancer. >Inhibition of miR‐24 suppresses malignancy of human non‐small cell lung cancer cells by targeting WWOX in vitro and in vivo
【24h】

Inhibition of miR‐24 suppresses malignancy of human non‐small cell lung cancer cells by targeting WWOX in vitro and in vivo

机译:抑制miR-24通过在体内外靶向WWOX来抑制人类非小细胞肺癌细胞的恶性肿瘤

获取原文
           

摘要

Background We investigated the effect of micro‐RNA 24 (miR‐24) and WWOX on non‐small cell lung cancer (NSCLC) cell proliferation and migration in vitro and in vivo. Methods We performed bioinformatics analysis and 3′ untranslated region luciferase assay to investigate the direct target of miR‐24. Proliferation, apoptosis, and transwell invasion assays were employed to evaluate the effect of WWOX overexpression with pcDNA3‐WWOX and knocking down miR‐24 with miR‐24 small interfering RNA. Quantitative real‐time PCR, Western blot, and immunohistochemistry were also used to investigate miR‐24 and c‐Kit expression, and apoptosis and invasion‐related proteins. Finally, we constructed a tumor xenograft model in nude mice to confirm the effect of miR‐24 on NSCLC cell proliferation in vivo. Results According to our experimental data, miR‐24 inhibition could induce apoptosis by activating caspase 3 and suppress the viability and proliferation of NSCLC cells in vitro and in vivo. MiR‐24 downregulation could reduce the invasive ability of NSCLC cells by downregulating MMP9. WWOX was identified as a functional target of miR‐24. WWOX overexpression generated the same effect with antagonizing miR‐24, while blocking WWOX counteracted the tumor suppressive effect caused by miR‐24 inhibition. MiR‐24 may function as an oncogene and play an important role in the cell growth and migration of NSCLC. Conclusions Our findings enhance understanding of the miR‐24 regulatory network and the molecular mechanism that underlies the oncogenesis and development of NSCLC. Suppressing the effect of miR‐24 on cancer cells using a miR‐24 inhibitor may be an attractive therapeutic strategy against NSCLC.
机译:背景我们研究了微小RNA 24(miR-24)和WWOX对非小细胞肺癌(NSCLC)细胞在体内外的增殖和迁移的影响。方法我们进行了生物信息学分析和3'非翻译区荧光素酶测定,以研究miR-24的直接靶标。增殖,凋亡和transwell入侵试验用于评估pcDNA3-WWOX过量表达WWOX和用miR-24小干扰RNA敲低miR-24的效果。实时定量PCR,Western印迹和免疫组化也用于研究miR-24和c-Kit表达以及凋亡和侵袭相关蛋白。最后,我们在裸鼠中建立了肿瘤异种移植模型,以确认miR-24对体内NSCLC细胞增殖的影响。结果根据我们的实验数据,miR-24抑制可通过激活caspase 3诱导凋亡,并抑制NSCLC细胞在体外和体内的活力和增殖。 MiR-24下调可能通过下调MMP9来降低NSCLC细胞的侵袭能力。 WWOX被确定为miR-24的功能靶标。 WWOX的过量表达与拮抗miR-24产生相同的效果,而阻断WWOX则抵消了miR-24抑制引起的肿瘤抑制作用。 MiR-24可能起癌基因的作用,并在非小细胞肺癌的细胞生长和迁移中起重要作用。结论我们的发现增强了对miR-24调控网络以及NSCLC发生和发展的分子机制的了解。使用miR-24抑制剂抑制miR-24对癌细胞的作用可能是针对NSCLC的有吸引力的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号